XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (33,517,735) $ (25,674,702)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 3,644,405 3,066,228
Stock-based 401K company common match 123,561 121,620
Depreciation expense 90,836 87,209
Impairment of machinery and equipment 2,672,581 0
Amortization of debt discount 1,039 22,012
Amortization of debt issuance costs 125,355 54,204
Non-cash interest expense 405,278 184,068
Changes in assets and liabilities:    
Prepaid expenses and other assets 556,401 317,643
Accounts payable (2,645,929) 824,032
Accrued expenses 602,322 940,303
Restructuring reserve 6,121,781 0
Net cash used in operating activities (21,820,105) (20,057,383)
Cash flows from investing activities:    
Purchases of property and equipment 0 (105,662)
Net cash used in investing activities 0 (105,662)
Cash flows from financing activities:    
Proceeds from issuance of debt 0 5,000,000
Proceeds from exercise of stock options 721,195 91,982
Proceeds from exercise of warrants 0 3,745
Payments for debt back-end fees (990,000) 0
Repayment of debt (20,000,000) 0
Proceeds from issuance of common stock, net of issuance costs 0 17,382,943
Net cash (used in) provided by financing activities (20,268,805) 22,478,670
Net (decrease) increase in cash (42,088,910) 2,315,625
Cash and cash equivalents at beginning of period 88,067,647 106,398,919
Cash and cash equivalents at end of period 45,978,737 108,714,544
Cash paid for:    
Interest 1,051,167 705,313
Supplemental cash flow information:    
Accrued capital expenditures included in accrued expenses and accounts payable $ 0 $ 55,089